Olema Pharmaceuticals inc (OLMA)
12.19
-0.03
(-0.25%)
USD |
NASDAQ |
Sep 27, 16:00
12.19
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Cash from Investing (Quarterly): -4.878M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -4.878M |
| March 31, 2024 | -20.14M |
| December 31, 2023 | -30.92M |
| September 30, 2023 | -25.44M |
| June 30, 2023 | 14.11M |
| March 31, 2023 | 37.39M |
| December 31, 2022 | 16.34M |
| September 30, 2022 | 20.16M |
| June 30, 2022 | 29.41M |
| Date | Value |
|---|---|
| March 31, 2022 | 25.57M |
| December 31, 2021 | 6.00M |
| September 30, 2021 | -12.78M |
| June 30, 2021 | 10.93M |
| March 31, 2021 | -279.58M |
| December 31, 2020 | -0.051M |
| September 30, 2020 | 0.01M |
| June 30, 2020 | -0.006M |
| March 31, 2020 | -0.009M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-279.58M
Minimum
Mar 2021
37.39M
Maximum
Mar 2023
-11.88M
Average
0.002M
Median
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -0.144M |
| Theriva Biologics Inc | -0.001M |
| Oragenics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.56M |
| Cash from Financing (Quarterly) | 15.60M |
| Free Cash Flow | -92.43M |
| Free Cash Flow Per Share (Quarterly) | -0.4897 |
| Free Cash Flow Yield | -14.32% |